Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

41.69 -1.07 (-2.50%)

Streaming Delayed Price Updated: 2:05 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B

November 12, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress

November 09, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present at Upcoming Healthcare Conferences

November 02, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology

October 03, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual Meeting

September 30, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 Activation

September 28, 2021

From Scholar Rock

Via Business Wire

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress

September 23, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference

September 22, 2021

From Scholar Rock

Via Business Wire

48 Biggest Movers From Yesterday ↗

September 21, 2021

Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...

Via Benzinga

Scholar Rock Appoints Caryn Parlavecchio as Chief Human Resources Officer

August 16, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress

August 10, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference

August 05, 2021

From Scholar Rock

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 03, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...

Via Benzinga

Scholar Rock Announces Leadership Change

August 03, 2021

From Scholar Rock

Via Business Wire

99 Biggest Movers From Yesterday ↗

August 06, 2021

Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...

Via Benzinga

Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress

June 18, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting

June 11, 2021

From Scholar Rock

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 09, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...

Via Benzinga

Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting

June 07, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present at Upcoming Healthcare Conferences in June

May 27, 2021

From Scholar Rock

Via Business Wire

42 Stocks Moving In Tuesday's Mid-Day Session ↗

May 25, 2021

Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's...

Via Benzinga

25 Stocks Moving in Tuesday's Pre-Market Session ↗

May 25, 2021

Gainers U.S. Well Services, Inc. (NASDAQ: USWS) rose 30.5% to $1.25 in pre-market trading after the company reported commitment to becoming all-electric hydraulic facturing...

Via Benzinga

A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Reports ↗

May 25, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq surged over 1% in the previous session. Investors are awaiting earnings results from...

Via Benzinga

7 Stocks Moving In Monday's After-Hours Session ↗

May 24, 2021

Gainers Scholar Rock (NASDAQ: SRRK) shares are trading higher after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 24, 2021

Gainers OptiNose (NASDAQ:OPTN) stock rose...

Via Benzinga

Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy

May 24, 2021

From Scholar Rock

Via Business Wire

Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting

May 19, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress

May 13, 2021

From Scholar Rock

Via Business Wire

Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy

May 11, 2021

From Scholar Rock

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.